SHIM
ARNA

Stone House Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Stone House Investment Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-18
Closed -$1K – 214
2019
Q1 		$1K Buy
+18
New +$826 ﹤0.01% 217

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Stone House Investment Management's ARNA Position: Q2 2019 in Review

Stone House Investment Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2019, closing a stake of 18 shares — an estimated $1K sold.

Stone House Investment Management first reported a position in ARNA in Q1 2019 and held it in 1 quarter. The position peaked at $1K in Q1 2019. 215 funds tracked by Wall St. Rank hold ARNA as of Q2 2019.

  • Stone House Investment Management reported no remaining Arena Pharmaceuticals Inc position as of Q2 2019 after selling out during the quarter.
  • Stone House Investment Management sold 18 Arena Pharmaceuticals Inc shares in Q2 2019, an estimated $1K.
  • Stone House Investment Management first reported a position in Arena Pharmaceuticals Inc in Q1 2019 and held it in 1 quarter.
  • Stone House Investment Management's Arena Pharmaceuticals Inc position peaked at $1K in Q1 2019.
  • 215 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2019.

Based on Stone House Investment Management's 13F filing for Q2 2019, filed 9 Jul 2019.